Clinical Trials Browser

Unknown × Chemotherapy, Adjuvant × Breast × Clear all

NCT01104571 2018-09-17

EPHOS-B

Phase 3 Unknown

Breast Neoplasms

NCT00301925 2018-08-08

TACT2

Phase 3 Unknown

Breast Neoplasms, Breast Neoplasms, Male

NCT02934828 2016-10-18

Study of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT02464774 2015-06-08

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Phase NA Unknown

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

NCT00436709 2014-01-06

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

Phase NA Unknown

Breast Neoplasms, Breast Neoplasms, Male

NCT00003678 2013-12-19

Tamoxifen in Treating Women With Breast Cancer

Phase 3 Unknown

20,000 enrolled

Breast Neoplasms

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00533936 2013-08-26

Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00002455 2013-08-07

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Phase 3 Unknown

BreastDermatologicGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Melanoma, Colorectal Neoplasms

NCT00039546 2013-08-07

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery

Phase 3 Unknown

Breast Neoplasms

NCT00516425 2013-08-07

Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00072020 2013-08-02

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis

NCT01031030 2013-08-02

Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009)

Phase 3 Unknown

Breast Neoplasms

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Phase 2 Unknown

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00002851 2010-01-29

Lymph Node Radiation Therapy in Patients With Stage I, Stage II, or Stage III Breast Cancer That Has Been Surgically Removed

Phase 3 Unknown

Breast Neoplasms

NCT00003016 2009-02-09

Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

Phase 3 Unknown

20,000 enrolled

Breast Neoplasms

NCT00033683 2009-02-09

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00077168 2009-02-09

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

Phase 2 Unknown

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating